Allspring Global Investments
GPCR icon

Allspring Global Investments’s Structure Therapeutics GPCR Stock Holding History

Allspring Global Investments’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-44,451
Closed -$1.75M – 2517
2024
Q2 		$1.75M Sell
44,451
-2,818
-6% -$116K ﹤0.01% 1204
2024
Q1 		$2.03M Sell
47,269
-816
-2% -$34.4K ﹤0.01% 1179
2023
Q4 		$1.96M Buy
+48,085
New +$2.76M ﹤0.01% 1185

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Allspring Global Investments's GPCR Position: Q3 2024 in Review

Allspring Global Investments sold out of Structure Therapeutics (GPCR) in Q3 2024, closing a stake of 44,451 shares — an estimated $1.75M sold.

Allspring Global Investments first reported a position in GPCR in Q4 2023 and held it in 3 quarters. The position peaked at $2.03M in Q1 2024. 160 funds tracked by Wall St. Rank hold GPCR as of Q3 2024.

  • Allspring Global Investments reported no remaining Structure Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 44,451 Structure Therapeutics shares in Q3 2024, an estimated $1.75M.
  • Allspring Global Investments first reported a position in Structure Therapeutics in Q4 2023 and held it in 3 quarters.
  • Allspring Global Investments's Structure Therapeutics position peaked at $2.03M in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.